In addition, it is evidenced that it has application in protein-aggregation-related. Value Proposition: The unique aspect of Anavex is that its drugs have multiple application than just Alzheimer's and Parkinson's. For example, Anavex 2-73 has applications to Rett Syndrome, Angelman Disease, and Fragile X. Due to the rareness of those diseases, Anavex receives facilitated and more prompt treatment from the FDA being granted Orphan Drug Designation ( ODD ) for ANAVEX TM 2-73 and a Phase 2, placebo-controlled trial in Parkinson's disease As an investor, this is what we look for: Diversification. If one application is not approved or is not proven to help, there are 4 other commercial applications. For this reason, from a pharmaceutical standpoint, I am long Financial Overview Quarter 3 results were still in the red, but the bleeding has been slowing (-.09 EPS). Increased spending for R&D, acquiring costs, assets, and administrative promote the belief that Anavex ( AVXL ) is growing and expanding.